Latest News about Exclusives
Recent news which mentions Exclusives
EXCLUSIVE: MIRA Pharmaceuticals Lead Program Ketamir-2 Shows No Brain Toxicity In FDA-Mandated Study
May 06, 2025
From Benzinga
From Benzinga
EXCLUSIVE: Thrill Ride With A Dividend? New ETF Marries MicroStrategy Leverage With Income
May 05, 2025
From Benzinga
From Benzinga
EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial
May 05, 2025
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
May 03, 2025
From Benzinga
EXCLUSIVE: April's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Apple, Palantir, Nvidia Stocks Rank?
May 02, 2025
From Benzinga
EXCLUSIVE: TransCode Therapeutics Reports Progress In Early-Stage Study For Lead Cancer Drug
May 01, 2025
From Benzinga
From Benzinga
EXCLUSIVE: If Meta Is Forced To Divest Instagram, WhatsApp, Or Facebook, 43% Pick This Standout
April 30, 2025
From Benzinga
EXCLUSIVE: Silo Pharma's Investigational Ketamine Implant Hits All Endpoints In Pain Study In Animal Models
April 30, 2025
From Benzinga
From Benzinga
EXCLUSIVE: Inside The Bond ETF That Thrives In Volatility—MacKay Shields' Zachary Aronson On How SECR Is Quietly Crushing It
April 29, 2025
Tickers
SECR
From Benzinga
EXCLUSIVE: Wix And ActiveCampaign Collaborate To Boost Engagement And Marketing Automation
April 29, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.